127 related articles for article (PubMed ID: 8059563)
1. [The manifestation of functional heterogeneity of the peptidoglycans in opsonophagocytic reactions].
Maianskiĭ AN; Sibiriakova NI; Astaf'ev DG; Fokina IuV
Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):114-8. PubMed ID: 8059563
[TBL] [Abstract][Full Text] [Related]
2. [Reactivity to Staphylococcus aureus peptidoglycan in a neutrophil phagocytosis system].
Boiarinova LV; Salina EV; Maianskaia IV; Maianskiĭ AN
Zh Mikrobiol Epidemiol Immunobiol; 1983 Dec; (12):49-53. PubMed ID: 6666448
[TBL] [Abstract][Full Text] [Related]
3. [The characteristics of Staphylococcus aureus peptidoglycan in the spectrum of the reactivity of human lymphocytes to bacterial peptidoglycans].
Osipov OA; Sibiriakova NI; Astaf'ev DG; Rassanov SP; Maianskiĭ AN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):60-2. PubMed ID: 1759526
[TBL] [Abstract][Full Text] [Related]
4. [Reactivity to bacterial peptidoglycans in a phagocytosis system. 1. The range of immunological specificity of Staphylococcus aureus peptidoglycan].
Maianskiĭ AN; Boiarinova LV; Azov NA; Maianskaia IV; Malysheva EF
Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):97-100. PubMed ID: 6207688
[TBL] [Abstract][Full Text] [Related]
5. [The response of human lymphocytes to Staphylococcus aureus peptidoglycan in a system of opsonic cooperation].
Maianskiĭ AN; Osipov OA; Astaf'ev DG
Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):46-8. PubMed ID: 1789035
[TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of the mediated neutrophil reactivity to Escherichia coli peptidoglycan].
Azov NA; Maianskiĭ AN
Zh Mikrobiol Epidemiol Immunobiol; 1985 Oct; (10):66-9. PubMed ID: 3911674
[TBL] [Abstract][Full Text] [Related]
7. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.
Wilkinson BJ; Peterson PK; Quie PG
Infect Immun; 1979 Feb; 23(2):502-8. PubMed ID: 422250
[TBL] [Abstract][Full Text] [Related]
8. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
[TBL] [Abstract][Full Text] [Related]
9. Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.
Verbrugh HA; van Dijk WC; Peters R; van Erne ME; Daha MR; Peterson PK; Verhoef J
J Immunol; 1980 Mar; 124(3):1167-73. PubMed ID: 7358981
[No Abstract] [Full Text] [Related]
10. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
11. [The range of antigenic specificity of Bifidobacterium peptidoglycan].
Sibiriakova NI; Astaf'ev DG; Maianskaia IV; Goncharova GI; Liannaia AM
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):2-3. PubMed ID: 1716036
[TBL] [Abstract][Full Text] [Related]
12. Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus.
Jung DJ; An JH; Kurokawa K; Jung YC; Kim MJ; Aoyagi Y; Matsushita M; Takahashi S; Lee HS; Takahashi K; Lee BL
J Immunol; 2012 Nov; 189(10):4951-9. PubMed ID: 23071283
[TBL] [Abstract][Full Text] [Related]
13. The staphylococcal surface-glycopolymer wall teichoic acid (WTA) is crucial for complement activation and immunological defense against Staphylococcus aureus infection.
Kurokawa K; Takahashi K; Lee BL
Immunobiology; 2016 Oct; 221(10):1091-101. PubMed ID: 27424796
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial properties of breast milk: requirements for surface phagocytosis and chemiluminescence.
Avery VM; Gordon DL
Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1034-9. PubMed ID: 1802694
[TBL] [Abstract][Full Text] [Related]
15. Host-parasite relationship in staphylococcal infections: the role of the staphylococcal cell wall during the process of phagocytosis.
Verhoef J; Peterson PK; Verbrugh HA
Antonie Van Leeuwenhoek; 1979; 45(1):49-53. PubMed ID: 552811
[TBL] [Abstract][Full Text] [Related]
16. [Reactivity of neutrophils in systems with peptidoglycans of different species of Staphylococcus].
Lebedeva IuV; Astaf'ev DG; Maianskiĭ AN
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):57-61. PubMed ID: 2800794
[TBL] [Abstract][Full Text] [Related]
17. Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins.
Vandenbroucke-Grauls CM; Thijssen HM; Verhoef J
Immunology; 1984 Jul; 52(3):427-35. PubMed ID: 6086502
[TBL] [Abstract][Full Text] [Related]
18. Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors.
Gordon DL; Rice JL
Immunology; 1988 Aug; 64(4):709-14. PubMed ID: 2971611
[TBL] [Abstract][Full Text] [Related]
19. Activation of the alternate complement pathway by peptidoglycan of Actinomyces viscosus, a potentially pathogenic oral bacterium.
Baker JJ; Billy SA
Arch Oral Biol; 1983; 28(11):1073-5. PubMed ID: 6362630
[TBL] [Abstract][Full Text] [Related]
20. Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides--studies on active components and structural requirements.
Kawasaki A; Takada H; Kotani S; Inai S; Nagaki K; Matsumoto M; Yokogawa K; Kawata S; Kusumoto S; Shiba T
Microbiol Immunol; 1987; 31(6):551-69. PubMed ID: 3670125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
